MaxCyte, Inc.

Healthcare

NASDAQ:MXCT · NASDAQ Global Select

Market Cap $119.98M Beta 1.67 P/E (TTM) -3.1

$1.12 +1.82%

+$0.02 today

52W Low $0.64High $2.37

Vol 0.49M · Avg 0.96M

EPS (TTM)-$0.37

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-49.09%

Period High

$2.33

Period Low

$0.68

Latest

$1.12

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Prenetics Global Limited

NASDAQ:PRE

$367.72M

Anteris Technologies Global Corp.

NASDAQ:AVR

$336.61M

Armata Pharmaceuticals, Inc.

AMEX:ARMP

$278.27M

Perspective Therapeutics, Inc.

AMEX:CATX

$227.89M

Profound Medical Corp.

NASDAQ:PROF

$200.47M

TriSalus Life Sciences, Inc.

NASDAQ:TLSI

$142.92M

Nano-X Imaging Ltd.

NASDAQ:NNOX

$122.48M

Owlet, Inc.

NYSE:OWLT

$84.14M

LENSAR, Inc.

NASDAQ:LNSR

$70.45M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$64.96M

What is the latest MXCT filing?

The latest filing shown is SC 13D dated May 14, 2026.

How many recent filings does MXCT have?

Intrinsic Alpha currently shows 20 recent filings for MXCT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.